National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011

Radiation Protection Dosimetry
Cécile EtardBernard Aubert

Abstract

A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv.

References

Feb 14, 2008·The British Journal of Radiology·P ScanffB Aubert
Nov 17, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Ronald BoellaardBernd J Krause

❮ Previous
Next ❯

Citations

May 6, 2014·Journal of the American College of Radiology : JACR·Yan QiaoYuan Liang
Mar 25, 2015·Radiation Protection Dosimetry·Sören MattssonMarcus Söderberg
Jan 22, 2014·Nuclear Medicine Communications·Gareth R Iball, Deborah Tout
Jan 20, 2017·The British Journal of Radiology·Matthew GardnerElizabeth A Larkin
Apr 30, 2017·Nuclear Medicine Communications·Gareth R IballTim Wood
Nov 10, 2018·British Dental Journal·N DrageR Lingam
Feb 17, 2019·Journal of Medical Imaging and Radiation Oncology·Essam M AlkhybariPeter L Kench
May 31, 2019·Radiation Protection Dosimetry·Yuhao LiLin Li
Jun 1, 2014·Nuclear Medicine Communications·Helena McMeekinDaniel McCool
Jan 11, 2018·International Journal of Radiation Biology·Maria GomolkaCarita Lindholm
Mar 3, 2017·Nuclear Medicine and Molecular Imaging·Sang-Geon ChoHo-Chun Song
Aug 24, 2018·Radiation Protection Dosimetry·Essam M AlkhybariPeter L Kench
Dec 10, 2019·European Journal of Nuclear Medicine and Molecular Imaging·G L PoliF Fahey
Apr 26, 2017·EJNMMI Research·Josep M Martí-ClimentJosé A Richter
Dec 18, 2019·EJNMMI Physics·Natalie A BebbingtonMarcus Söderberg
Mar 5, 2019·Nuclear Medicine and Molecular Imaging·Ho-Chun SongUNKNOWN Korean Society of Nuclear Medicine Diagnostic Reference Level Task Force
Sep 26, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Adam M AlessioFrederic H Fahey
Nov 14, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ngoneh JallowJonathon A Nye
Apr 5, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yusuke InoueToshimasa Hara
Jun 12, 2021·The British Journal of Radiology·Makoto HosonoYasumasa Nishimura
Aug 20, 2021·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Jelena PerićDejan Žontar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.